Testing effectiveness (Phase 2)Study completedNCT01590628
What this trial is testing
Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies
Who this might be right for
Sickle Cell Disease & Thalassemia
Gamida Cell ltd 16